Table 3.
Serum metabolic parameters and adipokines in different groups.
| Groups (n = 7) | ||||||
|---|---|---|---|---|---|---|
| Parameters | Control | SFD | MUFAs | PUFAs | MCFAs | SCFAs |
| Fasting glucose (mg/dl) | 90.04 ± 0.8 | 141.61a ± 1.61 | 116.14ab ± 0.8 | 116.66ab ± 1.4 | 120.6abcd ± 1 | 117.9ab ± 0.55 |
| Fasting insulin (µU/ml) | 9.86 ± 0.34 | 22a ± 1.59 | 16ab ± 0.82 | 16.01ab ± 1.18 | 17.21ab ± 0.89 | 16.43ab ± 0.35 |
| HOMA-IR | 2.19 ± 0.09 | 7.72a ± 0.64 | 4.61ab ± 0.27 | 4.61ab ± 0.38 | 5.14ab ± 0.31 | 4.78ab ± 0.12 |
| Leptin (pg/ml) | 242 ± 1.88 | 378.14a ± 3.01 | 278.71ab ± 2.87 | 276.14ab ± 3.63 | 312.29abcd ± 6.01 | 282.14abe ± 2.98 |
|
Adiponectin (ng/ml) |
8.87 ± 0.1 | 4.49a ± 0.07 | 7.3ab ± 0.24 | 7.63ab ± 0.19 | 6.13abcd ± 0.04 | 7.33abe ± 0.15 |
| Adiponectin/leptin ratio (pg/pg) | 36.6 ± 0.13 | 11.86a ± 0.1 | 26.14ab ± 0.64 | 27.6abc ± 0.38 | 19.66abcd ± 0.26 | 25.96abde ± 0.28 |
Data represent mean ± S.E. of observations from seven animals. a: significant from the control group. b: significant from long saturated fat (SFD) group, c: significant from monounsaturated (MUFAs) group, d: significant from polyunsaturated (PUFAs) group, e: significant from medium chain (MCFAs) group. significance: p < 0.05. SCFAs: short chain fatty acids, HOMA-IR: Homeostatic Model Assessment for insulin resistance.